Tilray EU
About Tilray EU
Tilray EU is the European arm of Tilray Brands, one of the world's largest cannabis companies. Operating from the Netherlands, Tilray EU manages cultivation, processing, and distribution of medical cannabis products across European markets. The company merged with Aphria in 2021, significantly expanding its European footprint.
Key Facts
- 1Parent company Tilray Brands trades on NASDAQ under TLRY with a multi-billion dollar valuation
- 2Merged with Aphria in 2021, creating one of the largest global cannabis companies
- 3Operates EU-GMP certified facilities in Portugal and Germany as well
- 4Distributes medical cannabis in over 20 countries worldwide
Latest News
Tilray Issues 1.6M Shares to Fund Lyphe Acquisition and Debt Reduction
TLRY dilutes equity base with new share issuance as company pursues European expansion through Lyphe Group buyout while addressing balance sheet concerns.
TLRY and ACB Rally as Retail Traders Target Cannabis Penny Stocks
Tilray Brands and Aurora Cannabis see renewed interest from penny stock traders, driving volume spikes amid broader cannabis sector volatility.
Cannabis Rescheduling Timeline Accelerates, Threatening TLRY Dominance
Federal cannabis rescheduling momentum builds as regulatory milestone approaches, creating headwinds for Tilray's market positioning and competitive moat.
Tilray Eyes Beer Empire Expansion Following BrewDog Strategic Move
Cannabis giant Tilray Brands leverages alcohol diversification strategy as company positions for broader beverage market penetration beyond core cannabis operations.
Tilray's Diversification Strategy Reshapes Cannabis Investment Thesis
TLRY's expansion beyond cannabis into alcohol and wellness creates new valuation framework as traditional sin stock categorization becomes outdated.
Frequently Asked Questions
What happened with the Tilray-Aphria merger?
In 2021, Tilray and Aphria completed a merger creating Tilray Brands. Aphria's strong European assets, including EU-GMP facilities, complemented Tilray's existing operations, making the combined entity a dominant force in European medical cannabis.
Does Tilray sell recreational cannabis in the Netherlands?
Tilray's Dutch operations focus on medical cannabis production and distribution. The company does not operate coffeeshops or sell recreational cannabis in the Netherlands.
How does Tilray EU differ from Tilray Canada?
Tilray EU operates under European pharmaceutical regulations (EU-GMP) and focuses exclusively on medical cannabis, while Tilray Canada also serves the recreational market. The EU operations serve as a distribution hub for medical products across Europe.
Cannabis Laws
Products
- Tilray medical cannabis flowers
- Full-spectrum cannabis oils
- EU-GMP medical products
- Branded cannabis preparations
Specialties
Company Details
- Location
- Lelystad, Netherlands
- Founded
- 2018
- Publicly Traded
- Yes
- Ticker
- NASDAQ:TLRY